Merck's Covid Pill Gets an FDA Hearing. What's at Stake for the Stock. – Barron's
Business News Merck’s Covid Pill Gets an FDA Hearing. What’s at Stake for the Stock. Barron’s FDA advisory group to review safety and efficacy of Merck’s Covid pill CNBC Is molnupiravir a turkey? Merck slips out drop in efficacy of COVID-19 antiviral over Thanksgiving period FierceBiotech While Merck’s COVID pill molnupiravir is poised for authorization, efficacy could hamper […]
